Skip to main content

Synlogic, Inc.

SYBX
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001527599

No open-market purchases or sales by Synlogic, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $16.7K in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Synlogic, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Synlogic, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Synlogic, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Sandell Scott DDirector, 10% Owner–Aug 14, 20261
New Enterprise Associates 14, L.P.Director, 10% Owner–Aug 14, 20261
NEA Partners 14, L.P.Director, 10% Owner–Aug 14, 20261
Nea 14 GP, LtdDirector, 10% Owner–Aug 14, 20261
Florence Anthony A. Jr.Director, 10% Owner–Aug 14, 20261
Makhzoumi MohamadDirector, 10% Owner–Aug 14, 20261
Dooley Mary BethSee Remarks below12,744Oct 31, 20251
Shea Richard PDirector15,506Apr 29, 20250
Flynn James PDirector15,000Apr 29, 20250
Awad AntoineChief Operating Officer33,859Apr 4, 20240
Barrett PeterDirector–Jan 4, 20240
Hurter Patricia N.Director–Jan 4, 20240
Brennan AoifePresident and CEO256,301Nov 14, 20230
Jensen Michael VangstedChief Financial Officer46,947Nov 14, 20230
Mathers Edward TDirector–Jun 26, 20230
Heffernan Michael ThomasDirector–Jun 26, 20230
Leschly NickDirector–Jun 26, 20230
Burgess Michael F.Director–Jun 26, 20230
Kelly-Croswell LisaDirector–Jun 26, 20230
Beloff GreggSee Remarks–Feb 1, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 14, 2026 (view filing)4:09 PM ETJul 2718 daysLateSandell Scott D and 5 othersDirector, 10% OwnerPPurchase+2.64M–––2.64M afterDerivative
Oct 31, 2025 (view filing)Oct 292 daysDooley Mary BethSee Remarks belowSSale−157$1.81−$284.17−1.2%12.7K after
Apr 3, 2025 (view filing)Apr 21 dayDooley Mary BethSee Remarks belowSSale−144$1.20−$172.8−1.1%12.9K after
Feb 4, 2025 (view filing)Feb 31 dayDooley Mary BethSee Remarks belowSSale−2.11K$1.33−$2.80K−13.9%13.0K after
Oct 30, 2024 (view filing)Oct 291 dayDooley Mary BethHead of FinanceSSale−79$1.40−$110.6−0.5%15.2K after
Apr 4, 2024 (view filing)Apr 22 daysDooley Mary BethHead of FinanceSSale−188$1.73−$325.24−1.2%15.2K after
Apr 4, 2024 (view filing)Apr 22 daysAwad AntoineChief Operating OfficerSSale−372$1.73−$643.56−1.1%33.9K after
Apr 5, 2023 (view filing)Apr 32 daysAwad AntoineChief Operating OfficerSSale−6.44K$0.58−$3.73K−7.9%74.7K after
Apr 5, 2023 (view filing)Apr 32 daysBrennan AoifeSee RemarksSSale−19.0K$0.58−$11.0K−6.9%256.3K after10b5-1
Apr 5, 2023 (view filing)Apr 32 daysJensen Michael VangstedChief Financial OfficerSSale−2.55K$0.58−$1.48K−5.2%46.9K after
May 25, 2022 (view filing)May 241 dayJensen Michael VangstedChief Financial OfficerPPurchase+9.50K$1.12+$10.6K+31.7%39.5K after
Apr 6, 2022 (view filing)Apr 42 daysBrennan AoifeSee RemarksSSale−8.89K$2.45−$21.8K−3.1%275.3K after
Apr 6, 2022 (view filing)Apr 42 daysAwad AntoineChief Operating OfficerSSale−2.65K$2.45−$6.49K−3.2%81.2K after